Skip to content

AVBP - ArriVent BioPharma, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

ArriVent BioPharma, Inc. Common Stock

AVBP · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AVBPArriVent BioPharma, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $35.83
52-wk low: $17.00
Prev close: $26.95
Mkt cap: $1.48B
Beta: 1.37
P/B: 4.0x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$353.3M

DS
D.E. Shaw
Q2 2026 13F
$30.3M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 7.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.5B

Valuation

P/B4.04

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AVBP
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.48B
Beta: 1.37

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-53.2%

$19.7M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$15.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for AVBP

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.05-7.1%

-$0.98 expected

Next report

What the street expects next

EPS expected

-$1.08

-$1.16 to -$1.03

Revenue expected

$0.00

10 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.11

Change in 30 days

-53.2%

ROA-33.1%

Growth

Beta1.37